Parnax Lab Limited (PARNAXLAB.BO)
INR 159.25
(-1.09%)
INR 159.25
(-1.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.17 Billion INR | 41.37% |
| 2022 | 828.12 Million INR | -21.27% |
| 2021 | 1.05 Billion INR | 42.84% |
| 2020 | 736.37 Million INR | -0.88% |
| 2019 | 742.89 Million INR | 26.18% |
| 2018 | 588.73 Million INR | 7.45% |
| 2017 | 547.91 Million INR | 1.28% |
| 2016 | 540.97 Million INR | 11.12% |
| 2015 | 486.85 Million INR | -15.52% |
| 2014 | 576.3 Million INR | -7.73% |
| 2013 | 624.56 Million INR | 49.15% |
| 2012 | 418.74 Million INR | -1.36% |
| 2011 | 424.5 Million INR | 51200.82% |
| 2010 | 827.47 Thousand INR | 351.31% |
| 2009 | 183.35 Thousand INR | -69.93% |
| 2008 | 609.69 Thousand INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -716.94 Million INR | -161.24% |
| 2023 FY | 1.17 Billion INR | 41.37% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 902.72 Million INR | 0.0% |
| 2023 Q4 | 1.17 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 828.12 Million INR | -21.27% |
| 2022 Q4 | 828.12 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 853.02 Million INR | 0.0% |
| 2021 Q4 | 1.05 Billion INR | 0.0% |
| 2021 FY | 1.05 Billion INR | 42.84% |
| 2021 Q2 | 909.75 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 692.16 Million INR | 0.0% |
| 2020 FY | 736.37 Million INR | -0.88% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 736.37 Million INR | 0.0% |
| 2019 Q4 | 742.89 Million INR | 0.0% |
| 2019 FY | 742.89 Million INR | 26.18% |
| 2019 Q2 | 561.68 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q2 | 563.09 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q4 | 588.73 Million INR | 0.0% |
| 2018 FY | 588.73 Million INR | 7.45% |
| 2017 FY | 547.91 Million INR | 1.28% |
| 2017 Q4 | 547.91 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 540.97 Million INR | 11.12% |
| 2016 Q2 | 590.04 Million INR | 0.0% |
| 2016 Q4 | 569.18 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 486.85 Million INR | -15.52% |
| 2015 Q2 | 519.22 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 486.85 Million INR | 0.0% |
| 2014 Q2 | 813.34 Million INR | 0.0% |
| 2014 FY | 576.3 Million INR | -7.73% |
| 2014 Q4 | 576.3 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q4 | 624.56 Million INR | 0.0% |
| 2013 FY | 624.56 Million INR | 49.15% |
| 2013 Q2 | 462.09 Million INR | 0.0% |
| 2012 FY | 418.74 Million INR | -1.36% |
| 2012 Q3 | - INR | 0.0% |
| 2012 Q4 | 418.74 Million INR | 0.0% |
| 2011 FY | 424.5 Million INR | 51200.82% |
| 2010 FY | 827.47 Thousand INR | 351.31% |
| 2009 FY | 183.35 Thousand INR | -69.93% |
| 2008 Q4 | 609.69 Thousand INR | 0.0% |
| 2008 FY | 609.69 Thousand INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -4455.115% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | -17.499% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -5477.48% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -2082.253% |
| Sunil Healthcare Limited | 902.83 Million INR | -29.671% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -54914.709% |
| MedPlus Health Services Limited | 14.27 Billion INR | 91.799% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | -16.567% |
| Patidar Buildcon Limited | 25.57 Million INR | -4478.105% |
| Roopa Industries Limited | 493.08 Million INR | -137.425% |
| Smruthi Organics Limited | 485.72 Million INR | -141.026% |
| Trident Lifeline Limited | 331.26 Million INR | -253.41% |
| PANJON LTD. | 25.38 Million INR | -4512.193% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -461.652% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -624.12% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -7715.695% |
| Anuh Pharma Limited | 1.54 Billion INR | 24.207% |
| Crestchem Limited | 23.94 Million INR | -4788.767% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -8633.405% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -890.258% |
| Tyche Industries Limited | 101.64 Million INR | -1051.812% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 37.102% |
| Trimurthi Limited | 101.36 Thousand INR | -1154904.933% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -479.635% |
| Norris Medicines Limited | 278.17 Million INR | -320.858% |
| Zenlabs Ethica Limited | 301.35 Million INR | -288.484% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -301.65% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 29.543% |
| Parmax Pharma Limited | 117.56 Million INR | -895.778% |
| Veerhealth Care Limited | 62.78 Million INR | -1764.787% |
| Deccan Health Care Limited | 111.33 Million INR | -951.513% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 31.705% |
| Makers Laboratories Limited | 569.18 Million INR | -105.684% |
| Lactose (India) Limited | 536.39 Million INR | -118.255% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | -40.517% |
| Zenith Healthcare Limited | 24.03 Million INR | -4770.867% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -654.982% |
| Bacil Pharma Limited | 1.12 Million INR | -103594.686% |
| PRAVEG LIMITED | 767.53 Million INR | -52.529% |
| Denis Chem Lab Limited | 289.82 Million INR | -303.942% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 31.787% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -480.734% |
| Colinz Laboratories Limited | 24.1 Million INR | -4756.723% |
| Godavari Drugs Limited | 957.86 Million INR | -22.221% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -391442.809% |
| Zenotech Laboratories Limited | 156.64 Million INR | -647.353% |
| Panchsheel Organics Limited | 340.2 Million INR | -244.123% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -139.719% |
| Vivanza Biosciences Limited | 148.63 Million INR | -687.664% |
| Phaarmasia Limited | 211.49 Million INR | -453.542% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 21.983% |
| Medi-Caps Limited | 63.01 Million INR | -1757.803% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -894.447% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -493.147% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | -3.52% |
| Mercury Laboratories Limited | 171.18 Million INR | -583.872% |
| Gennex Laboratories Limited | 535.21 Million INR | -118.738% |
| BDH Industries Limited | 312.53 Million INR | -274.586% |
| Coral Laboratories Limited | 281.83 Million INR | -315.384% |
| Concord Drugs Limited | 249.88 Million INR | -368.499% |
| Bharat Parenterals Limited | 2.65 Billion INR | 55.93% |
| Beryl Drugs Limited | 85.63 Million INR | -1267.08% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -568.341% |
| Evoq Remedies Limited | 116.23 Million INR | -907.221% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -635.354% |
| Transchem Limited | 6.72 Million INR | -17321.324% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -13095.593% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -2689.271% |
| Kerala Ayurveda Limited | 1.05 Billion INR | -10.69% |
| Cian Healthcare Limited | 1.03 Billion INR | -13.183% |
| Trinity League India Limited | 876 Thousand INR | -133543.037% |
| Syschem (India) Limited | 1.07 Billion INR | -9.339% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 42.697% |
| Natural Capsules Limited | 1.47 Billion INR | 20.748% |
| Auro Laboratories Limited | 433.09 Million INR | -170.312% |